2Balley DG,Dresser GK,Kreeft JH,et al.Grapefrut-feledipine interaction:effect of unprocessed fruit and robable ingredients [J].Clin Pharmacol Ther,2000,68:468
3Gegg CR.Drug interaction and anti-infective therapies[J].Am J Med,1999,106:227
4Nelson DR,Koymans L,kamataki T,et al.P450 superfamily:update on new sequences,gen mapping,accession numbers and nomenclature[J].Pharmacogenetics,1996,6 (1):1
5Drcss GK,Spence JD,Bailey DG.Pharmcokinetic-pharmacodynamic cousequences and clinical relevance of cytochrome P4503A4 inhibition [J].Clin Pharmacokenet,2000,38(1):41
6Commins CL,Wu CY,Benet LZ.Sex-related differences in the clearance of cytochrome P4503A4 substrate maybe caused by Pglycoprotein[J].Clin Pharmacol Ther,2002,72 (5):474
7Murray M,Cantrill E,Metha I,et al.Impaired expression of microsomal cytochrome P450 2C11 in choline-deficient rat liver during the development of cirrhosis[J].J Pharmacol Exp Ther,1992,261:373
8Lytton SD,Helander A,Zhiang-Gouillon ZQ,et al.Autoantibodies against cytochrome P-4502E1 and P-4503A in alcoholics[J].Mol Pharmacol ,1999,55:223
9Thummel KE,Shen DD,Podoll TD,et al.Use of midazolam as a human cytochrome P4503A probe:in vivo-in vitro correlation in liver trensplant patients[J].J Pharmaco Exp Ther ,1994,271:549
10Iwahori T,Matsuura T,Maehashe H,et al.CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartifical liver[ J ].Hepatology,2003,37(3):665
